Exit
Before you participate in this activity, please take this pre-assessment. Taking this pre-assessment does not immediately qualify learners to earn credit. 

Certificates of credit will only be sent to learners who also receive a passing score on the post-test (separate from this survey), and fill out the evaluation form and application for credit.

Question Title

* 1. Where are you in your career? 

Question Title

* 2. Patient with moderate to severe ulcerative colitis, initially treated with IFX now losing response despite adequate therapeutic drug level.

Which therapy/MOA is as effective in bio-exposed patients as it is in bio-naïve patients in the RCT that led to drug approval?

Question Title

* 3. At week 52 what is the percentage of patients treated with Mirikizumab for moderate to severe UC who achieved endoscopic improvement defined as an endoscopic Mayo score of 0 or 1 without friability (extra-point: delta Miri vs placebo induction)?

Question Title

* 4. Completing this pre-survey does not qualify you for a CME certificate. Only after completing the post-survey & evaluation form will a certificate be issued.

🔗 Proceed to activity on X/MondayNightIBD
🔗 Proceed to activity post-survey
(post-survey completion must occur on or after activity launch date and prior to activity expiration date to be valid for claiming credit)
( Privacy & Cookie Notice